日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrative multi-omics reveal a CD4⁺ T cell-derived six-gene signature linking the immune-stromal ecosystem to prognosis and immunotherapy selection in pancreatic cancer

整合多组学揭示了CD4⁺ T细胞来源的六基因特征,该特征将免疫基质生态系统与胰腺癌的预后和免疫治疗选择联系起来

Liang, Yuxin; Ma, Shuoshuo; Chen, Xing; Su, Yuhao; Zhong, Deyuan; Yan, Hongtao; Chen, Yahui; Wang, Ming; Leng, Zhengwei; Huang, Xiaolun

Efficacy and safety of postoperative adjuvant HAIC combining lenvatinib with or without PD-1 inhibitors in solitary large HCC: A multicenter retrospective study

术后辅助肝动脉灌注化疗联合乐伐替尼或不联合PD-1抑制剂治疗孤立性大肝癌的疗效和安全性:一项多中心回顾性研究

Liang, Yuxin; Wang, Ming; Zhong, Deyuan; Yan, Hongtao; Su, Yuhao; Chen, Xing; Huang, Xiaolun; Leng, Zhengwei

Dendritic cell-related gene signature in pancreatic cancer stratifies patient subtypes and implicates a KCTD14-TNF signaling axis

胰腺癌中树突状细胞相关基因特征可区分患者亚型,并提示KCTD14-TNF信号通路参与其中。

Liang, Yuxin; Gu, Yuheng; Zhang, Zilong; Zhong, Deyuan; Yan, Hongtao; Su, Yuhao; Chen, Yahui; Wang, Fei; Leng, Zhengwei; Huang, Xiaolun

FCGR2A defines prognostic immune subtypes and drives tumor progression in hepatocellular carcinoma.

FCGR2A 决定肝细胞癌的预后免疫亚型并驱动肿瘤进展。

Zhong Deyuan, Liang Yuxin, Yan Hongtao, Chen Xing, Chen YaHui, Ma Shuoshuo, Su Yuhao, Wang Fei, Chen Xinpei, Yang Qinyan, Leng Zhengwei, Wang Ming, Huang Xiaolun

Diagnosis and treatment of Ascarial pancreatitis: a case report and literature review

蛔虫性胰腺炎的诊断和治疗:病例报告及文献综述

He, Hongyu; Guo, Hao; Li, Zhongtao; Wang, Shu; Zhou, GuoJun; Liu, Zhi; Chen, Jianyu; Leng, Zhengwei; Xie, Liang

Epiregulin drives keratinocyte hyperproliferation in sorafenib-induced hand-foot skin reaction: A mechanistic and therapeutic insight

表皮调节蛋白驱动索拉非尼诱导的手足皮肤反应中角质形成细胞过度增殖:机制和治疗启示

Liang, Yuxin; Hong, Xiao; Zhong, Xiaorong; Chen, Ke; Wang, Jie; Zhao, Jingbin; Li, Zhao; Wu, Jianlin; Zhou, Guojun; Huang, Xiaolun; Leng, Zhengwei

Regorafenib plus programmed death‑1 inhibitors vs. regorafenib monotherapy in second‑line treatment for advanced hepatocellular carcinoma: A systematic review and meta‑analysis

瑞戈非尼联合程序性死亡受体-1抑制剂与瑞戈非尼单药治疗晚期肝细胞癌二线治疗的疗效比较:系统评价和荟萃分析

Li, Zhao; Wang, Jie; Zhao, Jingbing; Leng, Zhengwei

Krüppel-like factor 4 regulates stemness and mesenchymal properties of colorectal cancer stem cells through the TGF-β1/Smad/snail pathway

Krüppel样因子4通过TGF-β1/Smad/Snail信号通路调控结直肠癌干细胞的干性和间质特性。

Leng, Zhengwei; Li, Yong; Zhou, Guojun; Lv, Xiaojiang; Ai, Walden; Li, Jianshui; Hou, Lingmi

MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1

MicroRNA-155 的表达与胃癌的病理分期呈负相关,它通过靶向细胞周期蛋白 D1 来抑制胃癌细胞的生长。

Ma, Zhijun; Ma, Yulan; Xia, Qinghua; Li, Yong; Li, Ruidong; Chang, Weilong; Chen, Jinhuang; Leng, Zhengwei; Tao, Kaixiong

Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells

Krüppel样因子4在富含结肠癌干细胞的球状细胞中发挥癌基因的作用。

Leng, Zhengwei; Tao, Kaixiong; Xia, Qinghua; Tan, Jun; Yue, Zhongyi; Chen, Jinhuang; Xi, Hailin; Li, Jie; Zheng, Hai